Table 2. GO:C5 MS5-upregulated mRNA pathways.

Gene Set Description	P	# Up	# Down
Cellular Component	(none met criterion P<0.01)
Molecular Function
3',5'-cAMP Phosphodiesterase Activity	0.003	11	2
Cyclic Nucleotide Phosphodiesterase Activity	0.004	12	2
N-methyltransferase Activity	0.001	8	5
Oxidoreductase Activity	0.008	18	12
Phosphatase Inhibitor Activity	0.001	10	1
Phosphatase Regulator Activity	0.009	19	6
Serotonin Receptor Activity	0.001	7	3
SH2 Domain Binding	0.005	11	4
Sodium Channel Activity	0.008	10	5
Transcription Elongation Regulator Activity	0.009	7	3
Biological Process
B Cell Activation	0.008	11	8
Behavior	0.003	76	57
Calcium-mediated Signaling	0.003	11	4
cAMP-Mediated Signaling	0.004	40	23
Cell Activation	0.007	38	30
Central Nervous System Development	0.0002	64	53
Chromosome Organization and Biogenesis	0.003	7	3
Endothelial Cell Proliferation	0.0001	7	3
G Protein Receptor Pathway	0.0004	175	142
Hormone Secretion	0.002	12	4
Leukocyte Differentiation	0.010	21	14
Lymphocyte Activation	0.010	13	7
Multicellular Organismal Process	0.0002	76	62
Muscle Contraction	0.0001	13	5
Myeloid Cell Differentiation	0.005	11	6
Negative Regulation of Catalytic Activity	0.003	37	28
Neurological System Process	0.004	201	152
Positive Regulation of Cell Adhesion	0.001	8	3
Regulation of Homeostasis	0.003	8	4
Response to Extracellular Stimulus	0.007	18	14
Second Messenger-mediated Signaling	0.001	85	61

Gene sets (GO:C5) with mRNAs exhibiting upregulated expression due to neonatal morphine (MS5) exposure. Alphabetical order.